Cadence Capital Management’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Cadence Capital Management’s Portfolio BSTC Stock Details BSTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	$436K	Sell	8,261 -26,925	-77%	-$1.66M	0.11%	157
2020 Q2	$2.16M	Sell	35,186 -8,762	-20%	-$507K	0.31%	70
2020 Q1	$2.49M	Sell	43,948 -2,287	-5%	-$130K	0.42%	58
2019 Q4	$2.63M	Buy	46,235 +10,549	+30%	+$559K	0.28%	76
2019 Q3	$1.91M	Sell	35,686 -305	-0.8%	-$17.8K	0.27%	150
2019 Q2	$2.15M	Sell	35,991 -1,205	-3%	-$75.8K	0.22%	151
2019 Q1	$2.32M	Sell	37,196 -16,281	-30%	-$1.08M	0.21%	147
2018 Q4	$3.24M	Buy	53,477 +4,114	+8%	+$246K	0.33%	73
2018 Q3	$2.89M	Buy	+49,363	New	+$2.52M	0.16%	167
2017 Q4	–	Sell	-29,586	Closed	-$1.38M	–	682
2017 Q3	$1.38M	Buy	29,586 +1,433	+5%	+$68.6K	0.09%	317
2017 Q2	$1.39M	Buy	28,153 +1,538	+6%	+$80.6K	0.1%	269
2017 Q1	$1.46M	Buy	26,615 +4,840	+22%	+$256K	0.1%	232
2016 Q4	$1.21M	Buy	21,775 +526	+2%	+$25.3K	0.09%	294
2016 Q3	$970K	Sell	21,249 -149	-0.7%	-$5.98K	0.07%	321
2016 Q2	$855K	Buy	+21,398	New	+$784K	0.06%	329
2015 Q4	–	Sell	-20,973	Closed	-$913K	–	672
2015 Q3	$913K	Buy	20,973 +10,313	+97%	+$557K	0.06%	312
2015 Q2	$550K	Buy	+10,660	New	+$455K	0.03%	524

Other funds holding BSTC

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Cadence Capital Management's BSTC Position: Q3 2020 in Review

Cadence Capital Management reduced its BioSpecifics Technologies Corp. (BSTC) stake by 77% in Q3 2020, selling an estimated $1.66M and leaving 8,261 shares worth $436K. The position accounts for 0.11% of the portfolio, ranked #157.

Cadence Capital Management first reported a position in BSTC in Q2 2015 and has held it in 17 quarters since. The position peaked at $3.24M in Q4 2018. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

Cadence Capital Management held 8,261 shares of BioSpecifics Technologies Corp. worth $436K as of Q3 2020.
Cadence Capital Management sold 26,925 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $1.66M.
BioSpecifics Technologies Corp. made up 0.11% of Cadence Capital Management's portfolio in Q3 2020, its #157 holding.
Cadence Capital Management first reported a position in BioSpecifics Technologies Corp. in Q2 2015 and has held it in 17 quarters since.
Cadence Capital Management's BioSpecifics Technologies Corp. position peaked at $3.24M in Q4 2018.
113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.